<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Renal hypodysplasia
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Renal hypodysplasia
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Renal hypodysplasia
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Patrick Niaudet, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Tej K Mattoo, MD, DCH, FRCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 10, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H805356015">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disruption of normal renal development can lead to congenital anomalies of the kidney and urinary tract (CAKUT), including renal hypodysplasia, which is characterized by congenitally small kidneys with a reduced number of nephrons and dysplastic features.
        </p>
        <p>
         Renal hypodysplasia, including its pathogenesis, etiologies, presentation, diagnosis, and management will be discussed here. Other CAKUT are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">
          "Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3438548192">
         <span class="h1">
          RENAL MALFORMATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Normal renal development is dependent upon the interaction between the ureteric bud and metanephric mesenchyme, which induces organogenesis. The average of number of nephrons is approximately 900,000 to 1 million per kidney, but there is a wide range, extending from 200,000 to &gt;2.5 million nephrons per kidney  (
         <a class="graphic graphic_figure graphicRef68500" href="/z/d/graphic/68500.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. Nephrogenesis, which starts at 10 weeks of human gestation, can be disturbed by mutations in genes that are involved in this process or by environmental factors, such as nutritional deficiencies during pregnancy. Nephron formation is completed at 36 weeks gestation. (See
         <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">
          "Overview of congenital anomalies of the kidney and urinary tract (CAKUT)", section on 'Embryology'
         </a>
         .)
        </p>
        <p>
         Renal parenchymal malformations include the following (see
         <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">
          "Overview of congenital anomalies of the kidney and urinary tract (CAKUT)", section on 'Kidney parenchymal malformations'
         </a>
         and
         <a class="local">
          'Pathogenesis'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal aplasia (agenesis) – Congenital absence of kidney(s). (See
         <a class="medical medical_review" href="/z/d/html/6746.html" rel="external">
          "Renal agenesis: Prenatal diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal hypoplasia – Congenitally small kidneys with a reduced number of nephrons but normal architecture.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal dysplasia – The presence of malformed renal tissue elements, including primitive tubules, interstitial fibrosis, and/or the presence of cartilage in the renal parenchyma. Dysplastic kidneys often contain cysts. (See
         <a class="medical medical_review" href="/z/d/html/6144.html" rel="external">
          "Kidney cystic diseases in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal hypodysplasia – Congenitally small kidney (reduced number of nephrons) with dysplastic features. Renal hypoplasia is more commonly associated with dysplasia than without.
        </p>
        <p>
        </p>
        <p>
         These malformations, along with lower urinary tract abnormalities, constitute a spectrum of disorders referred to as congenital anomalies of the kidney and urinary tract (CAKUT). CAKUT occur in 1 to 3 in 500 live births and account for 40 to 50 percent of chronic renal disease cases in children [
         <a href="#rid2">
          2
         </a>
         ]. Approximately 30 percent of CAKUT cases are either syndromic or occur within a familial aggregation. However, in most cases, anomalies are restricted to only the renal tract and are sporadic in nature. Renal malformations may be unilateral or bilateral and may occur in association with urinary tract anomalies, such as vesicoureteral reflux (VUR). (See
         <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">
          "Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6115.html" rel="external">
          "Chronic kidney disease in children: Definition, epidemiology, etiology, and course", section on 'Etiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H679929066">
         <span class="h2">
          Pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathology of renal dysplasia and hypoplasia are as follows. Most patients with renal hypoplasia have dysplastic features (
         <strong>
          renal hypodysplasia
         </strong>
         ) and will have pathologic features of both renal dysplasia and hypoplasia.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Kidney dysplasia is characterized by the presence in the renal parenchyma of dysplastic elements such as primitive tubules surrounded by undifferentiated stroma, metaplastic cartilage, and smooth muscle, often with cystic tubule dilatations  (
         <a class="graphic graphic_picture graphicRef54805" href="/z/d/graphic/54805.html" rel="external">
          picture 1
         </a>
         ). Dysplasia may affect a segment of the kidney, for example, in the upper part of a duplex kidney, or the entire kidney.
        </p>
        <p>
        </p>
        <p>
         Kidney dysplasia is a histologic definition, although histologic confirmation is typically not needed for diagnosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Kidney hypoplasia without dysplasia (oligomeganephronic renal hypoplasia) [
         <a href="#rid3">
          3
         </a>
         ] is characterized by the following histopathologic features [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Smaller kidneys – Kidney weight that is less than 50 percent of age-matched normal controls.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Low number of nephrons – The kidneys of patients with renal hypoplasia have only 20 to 25 percent of the normal total number of nephrons.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypertrophic glomeruli – The diameter of glomeruli is twice the normal glomerular size (250 to 325 microns versus 100 to 150 microns).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypertrophic tubules – Affected tubules are both longer (four times the normal length) and larger (15 times the normal volume for age) than normal.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other findings – Thickening of Bowman's capsule and variable abnormalities of the glomerular basement membrane (GBM) are seen. Electron microscopy also reveals irregular thickening and fusion of epithelial cell foot processes [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Over time, these patients develop end-stage renal disease (ESRD) with histologic changes that include interstitial fibrosis and tubular atrophy  (
         <a class="graphic graphic_picture graphicRef51309" href="/z/d/graphic/51309.html" rel="external">
          picture 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2501763522">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal hypodysplasia is believed to result from developmental arrest of the metanephric renal blastema during the first trimester of fetal life [
         <a href="#rid6">
          6
         </a>
         ]. Although it remains unknown what causes renal hypodysplasia, two possible mechanisms include in utero vascular abnormalities and genetic developmental disorders.
        </p>
        <p>
         Support for a major defect in the development of the renal blastema as a contributing cause of renal hypodysplasia in humans was provided by histological examination of two cases of oligomeganephronia with contralateral renal agenesis [
         <a href="#rid7">
          7
         </a>
         ]. In both cases (an 18-week-old fetus and a preterm infant), the development of the metanephric blastema was deficient, resulting in a reduced blastema compared with normal controls [
         <a href="#rid7">
          7
         </a>
         ]. Additional findings included a reduction in the number of glomeruli per gram of parenchyma, and severe hypertrophy combined with a decreased number of nephron generations.
        </p>
        <p>
         Renal hypodysplasia may be an isolated finding or a component of a genetic syndrome (eg, renal-coloboma and branchio-oto-renal [BOR] syndromes) associated with urinary tract malformations.
        </p>
        <p class="headingAnchor" id="H1354381983">
         <span class="h1">
          ETIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H655193859">
         <span class="h2">
          Vascular abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Support for in utero vascular abnormalities includes several cases of renal hypoplasia affecting only one of two homozygous twins [
         <a href="#rid8">
          8,9
         </a>
         ]. In these cases, a placenta vascular shunt at a critical developmental period appears to have impaired kidney development. Other types of vascular accidents also might be involved, including disseminated intravascular coagulation or embolization of necrotic pieces, following the death in utero of a twin fetus [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2649154254">
         <span class="h2">
          Renal hypodysplasia and urinary tract abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal hypodysplasia may be observed in patients with urinary tract disorders, such as posterior urethral valves (PUV), vesicoureteral reflux (VUR), and ureteropelvic junction obstruction (UPJO) [
         <a href="#rid11">
          11
         </a>
         ]. Proposed mechanisms for both renal and urinary tract disorders include either a common developmental insult or back pressure from urinary tract obstruction resulting in disrupted renal development and renal hypodysplasia. (See
         <a class="medical medical_review" href="/z/d/html/6575.html" rel="external">
          "Clinical presentation and diagnosis of posterior urethral valves", section on 'Chronic kidney disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6585.html" rel="external">
          "Congenital ureteropelvic junction obstruction", section on 'Pathophysiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6094.html" rel="external">
          "Clinical presentation, diagnosis, and course of primary vesicoureteral reflux", section on 'Congenital renal hypodysplasia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1901021448">
         <span class="h2">
          Genetic disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal hypodysplasia is observed in over 200 syndromic disorders where anomalies involving other organs are present. In several of these syndromic disorders, mutations of genes involved in renal tract development have been identified  (
         <a class="graphic graphic_table graphicRef108138" href="/z/d/graphic/108138.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid12">
          12,13
         </a>
         ]. These genes encode transcriptional factors or other factors, which regulate early renal development and have extrarenal functions, and which explain the extrarenal phenotypes. A large case series reported that a genetic defect was identified in 6 percent of patients with CAKUT, and the most prevalent disease-causing genes included
         <em>
          SALL1
         </em>
         ,
         <em>
          HNF1B
         </em>
         , and
         <em>
          PAX2
         </em>
         [
         <a href="#rid14">
          14
         </a>
         ]. Other gene mutations such as
         <em>
          SIX2
         </em>
         and
         <em>
          BMP4
         </em>
         [
         <a href="#rid15">
          15
         </a>
         ],
         <em>
          UPIIIa
         </em>
         [
         <a href="#rid16">
          16
         </a>
         ], or
         <em>
          DSTYK
         </em>
         [
         <a href="#rid17">
          17
         </a>
         ] also have been associated with isolated or sporadic non-syndromic cases of CAKUT. In addition, whole exome sequencing performed in 202 patients identified
         <em>
          GREB1L
         </em>
         and
         <em>
          SLIT3
         </em>
         as genes implicated in the pathogenesis of renal hypodysplasia [
         <a href="#rid18">
          18
         </a>
         ]. Copy gene variants with deletions or duplications of regions such as 1q21, 4p16.1-6.3, 16p11.2, 16p13.11, 17q12, or 22q11.2 have been identified in patients with syndromic or nonsyndromic forms of renal hypodysplasia [
         <a href="#rid19">
          19
         </a>
         ]. Several of these genetic syndromic disorders are discussed.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal tubular dysgenesis
         </strong>
         – Autosomal recessive renal tubular dysgenesis (RTD;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F267430&amp;token=G%2BkOOgscg7PQzd0gXq5S97L5sau2W3PnxT6wJ2SgF0yHCO5I2IkvNIli0%2BWb1u5U&amp;TOPIC_ID=6083" target="_blank">
          OMIM #267430
         </a>
         ) is a disorder of renal tubular development secondary to the hypoperfusion of the embryonic kidney [
         <a href="#rid20">
          20,21
         </a>
         ]. Clinical manifestations consist of persistent fetal anuria resulting in oligohydramnios and pulmonary hypoplasia, persistent anuria, and arterial hypotension [
         <a href="#rid22">
          22
         </a>
         ]. Most patients die in the perinatal period due to pulmonary hypoplasia and 10 to 15 percent survive with intensive care [
         <a href="#rid23">
          23
         </a>
         ]. Renal histology shows an absence or paucity of differentiated proximal tubules. It is associated with skull ossification defects. Homozygous or compound heterozygous mutations of the genes encoding for the renin-angiotensin system have been identified as the underling etiology. These include renin (
         <em>
          REN
         </em>
         ), angiotensinogen (
         <em>
          AGT
         </em>
         ), angiotensin-converting enzyme (
         <em>
          ACE
         </em>
         ), angiotensin II receptor type 1 (
         <em>
          AGTR1
         </em>
         ) [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Renal tubular dysgenesis can also be caused by renal hypoperfusion in the first trimester due to twin-twin syndrome or prenatal exposure to angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Branchio-oto-renal syndrome
         </strong>
         – Branchio-oto-renal (BOR) syndrome (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F113650&amp;token=G%2BkOOgscg7PQzd0gXq5S94wQV9pbTmeSGli9Z%2FjAfufAEbwcOHg9ngBCwCukAWHw&amp;TOPIC_ID=6083" target="_blank">
          OMIM #113650
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F610896&amp;token=G%2BkOOgscg7PQzd0gXq5S9%2FE59Qr%2F1Gwg%2FmYPmcY%2BdGHRalIZGajmBmH6Re7MhThq&amp;TOPIC_ID=6083" target="_blank">
          #610896
         </a>
         ), is an autosomal dominant disorder characterized by branchial defects with lateral cervical fistulas or cysts, ear pits, hearing loss, and renal anomalies, including renal aplasia and hypoplasia [
         <a href="#rid26">
          26-28
         </a>
         ]. The incidence of BOR syndrome is 1 in 40,000 infants. In this syndrome, penetrance is incomplete, and patients may have only one or two features of the syndrome [
         <a href="#rid29">
          29
         </a>
         ]. Renal anomalies are not observed in all patients and may differ in individuals of the same family. Renal findings include renal agenesis or hypoplasia (which may be unilateral or bilateral), VUR, UPJO, or ureteral duplication [
         <a href="#rid26">
          26,27
         </a>
         ]. If renal hypoplasia is present, it may vary in severity and may progress to end-stage renal disease (ESRD). Ear abnormalities include periauricular pits, anomalies of the middle and external ear, and hypoplasia of the cochlea, resulting in hearing loss. (See
         <a class="medical medical_review" href="/z/d/html/6299.html" rel="external">
          "Congenital anomalies of the ear", section on 'Preauricular pits'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         More than 80 mutations in the
         <em>
          EYA1
         </em>
         gene on chromosome 8q13.3 have been identified in patients with BOR syndrome [
         <a href="#rid27">
          27,30,31
         </a>
         ]. The
         <em>
          EYA1
         </em>
         gene encodes for a transcription cofactor that is expressed in the metanephric mesenchyme during kidney development [
         <a href="#rid32">
          32
         </a>
         ]. The
         <em>
          EYA1
         </em>
         gene interacts with members of the
         <em>
          SIX
         </em>
         gene family, which encodes transcription factors that control expression of the PAX2 and GDNF
         <em>
         </em>
         protein products in the metanephric mesenchyme. Mutations in
         <em>
          SIX1
         </em>
         (chromosome 14q23.1) and
         <em>
          SIX5
         </em>
         genes have also been reported in families with the BOR syndrome [
         <a href="#rid33">
          33-35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal-coloboma syndrome
         </strong>
         – Renal-coloboma syndrome (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F120330&amp;token=G%2BkOOgscg7PQzd0gXq5S9yU50bqaH1qizHKr6mN0FJxjRR23GbcypXD8rqhIZu2b&amp;TOPIC_ID=6083" target="_blank">
          OMIM #120330
         </a>
         ), also known as the papillorenal syndrome, is an autosomal dominant disorder characterized by renal hypoplasia and optic nerve coloboma [
         <a href="#rid36">
          36
         </a>
         ]. Renal malformations include renal hypodysplasia, VUR, and less often, multicystic dysplasia and UPJO [
         <a href="#rid37">
          37
         </a>
         ]. Ophthalmologic examination shows an optic disc split and vascular anomalies associated with variable visual impairment [
         <a href="#rid38">
          38
         </a>
         ]. Some patients have a large coloboma of the optic nerve while other patients present with optic nerve dysplasia without visual impairment. Other features include sensorineural hearing loss (SNHL), Arnold-Chiari malformation, seizures, and joint laxity [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6267.html" rel="external">
          "Congenital and acquired abnormalities of the optic nerve", section on 'Optic disc coloboma'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         More than 50 heterozygous mutations in the
         <em>
          PAX2
         </em>
         gene have been described in patients with the renal-coloboma syndrome [
         <a href="#rid40">
          40,41
         </a>
         ]. Identified mutations have mostly been located in the second and third exons of the
         <em>
          PAX2
         </em>
         gene, which is located on chromosome 10q24-25 [
         <a href="#rid40">
          40
         </a>
         ]. The
         <em>
          PAX2
         </em>
         gene encodes a transcription factor involved in the development of the kidneys and eyes.
         <em>
          PAX2
         </em>
         mutations have been identified in a few patients with renal hypodysplasia and limited or no optic nerve anomalies [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          HNF1b-related disease (renal cysts and diabetes syndrome)
         </strong>
         – Heterozygous mutations of
         <em>
          HNF1b
         </em>
         gene are responsible for an autosomal dominant disease referred to as renal cysts and diabetes (RCAD) syndrome (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F137920&amp;token=G%2BkOOgscg7PQzd0gXq5S9zZF4rPQpDJnacqJb3d9su7v2bvKultgnUZDG5Xq0cxH&amp;TOPIC_ID=6083" target="_blank">
          OMIM #137920
         </a>
         ). Antenatal ultrasound examination may detect this disorder based on characteristic findings, which include enlarged hyperechogenic kidneys, renal cysts, renal dysplasia, unilateral or bilateral multicystic kidney disease (MCKD), or unilateral renal agenesis [
         <a href="#rid44">
          44
         </a>
         ]. During childhood, kidney size decreases while renal cysts increase in size. Progression to renal failure is observed during childhood in half of the patients [
         <a href="#rid45">
          45
         </a>
         ]. Renal histology shows glomerular cysts or cysts developed in any part of the nephron and often renal dysplasia. Renal cell carcinoma may develop later in life [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Extrarenal manifestations include [
         <a href="#rid47">
          47
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diabetes mellitus typically presents in adolescence but may have occur in affected neonates [
         <a href="#rid48">
          48,49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1793.html" rel="external">
          "Classification of diabetes mellitus and genetic diabetic syndromes", section on 'Hepatocyte nuclear factor-1-beta'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased risk of autism and schizophrenia [
         <a href="#rid50">
          50,51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In adults, exocrine pancreas deficiency and asymptomatic cholestasis with increased levels of gamma-glutamyl transpeptidase (GGT) but without liver histologic anomalies may develop.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other abnormalities include hypomagnesemia, hyperuricemia, and urogenital tract anomalies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The
         <em>
          HNF1b
         </em>
         gene is located on chromosome 17q12 and encodes for a transcription factor, which controls the expression of several genes involved in development in the liver, the kidneys, the intestine, and the pancreas. A deletion of the whole gene is observed in 50 to 60 percent of patients while other patients show small mutations. De novo mutations occur in more than 50 percent of cases. The severity of the renal disease associated with
         <em>
          HNF1b
         </em>
         mutations is extremely variable and is not correlated with the genotype [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DiGeorge syndrome
         </strong>
         – DiGeorge syndrome (OMIM #188400) is a microdeletion syndrome, most often sporadic due to a de novo deletion of chromosome 22 (22q11.2). It is characterized by cardiac malformations, hypoparathyroidism, immune deficiency, and developmental delay. CAKUT are observed in 30 percent of patients with DiGeorge syndrome. A recurrent 370-kb deletion at the 22q11.2 locus that contains nine genes has been identified as the genetic driver of kidney defects in the DiGeorge syndrome and in sporadic CAKUT [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Townes-Brocks syndrome
         </strong>
         – Townes-Brocks syndrome (TBS;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F107480&amp;token=G%2BkOOgscg7PQzd0gXq5S9yCQjWPt31vuaSlqllB2u0j4uxzv3gWJayx%2FiP7r8Hp2&amp;TOPIC_ID=6083" target="_blank">
          OMIM #107480
         </a>
         ), also referred to as anus-hand-ear syndrome, is an autosomal dominant disorder characterized by the association of imperforate anus, preaxial polydactyly and triphalangeal thumbs, external ear anomalies, SNHL, and renal and cardiac anomalies [
         <a href="#rid54">
          54
         </a>
         ]. Renal malformations consist of unilateral or bilateral hypoplastic and/or dysplastic kidneys, renal agenesis, multicystic kidney, horseshoe kidney, VUR, and PUV. These malformations may be responsible for renal failure, including ESRD. Most patients have normal intelligence.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         TBS occurs in 1 in 200,000 live births. More than 60 mutations have been identified in
         <em>
          SALL1
         </em>
         gene on chromosome 16q12.1, which codes for a zinc finger transcription factor involved in kidney development [
         <a href="#rid55">
          55,56
         </a>
         ].
         <em>
          SALL1
         </em>
         is essential for ureteric bud invasion, the first step of metanephros development [
         <a href="#rid57">
          57
         </a>
         ]. De novo mutations are observed in 50 percent of cases. Approximately 65 percent of patients have point mutations, and 5 percent deletions [
         <a href="#rid58">
          58
         </a>
         ]. Severity of the disease varies and is not correlated with the genotype.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Kallmann syndrome
         </strong>
         – Kallmann syndrome (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F308700&amp;token=G%2BkOOgscg7PQzd0gXq5S95aGIrmw2hhR9Zs2%2BUdvoRulflf1%2FeBG1c7id43YaeOT&amp;TOPIC_ID=6083" target="_blank">
          OMIM #308700
         </a>
         ) is defined by the association of hypogonadotrophic hypogonadism and anosmia or hyposmia. Some patients also present with cleft lip, heart defects, obesity, and cognitive impairment [
         <a href="#rid59">
          59
         </a>
         ]. Renal malformations include unilateral renal agenesis and, less frequently, hydronephrosis or VUR.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The association of hypogonadotrophic hypogonadism and anosmia is explained by the embryologic origin of gonadotrophin-releasing hormone (GnRH)-producing neurons and olfactory sensory neurons whose precursors migrate together during development from the nasal placode to the telencephalon. This migration is regulated by neurotransmitters, extracellular matrix proteins, and growth factors. Kallmann syndrome is genetically heterogeneous. Anomalies have been found in six different genes (
         <em>
          KAL1
         </em>
         ,
         <em>
          FGFR1
         </em>
         ,
         <em>
          FGF8
         </em>
         ,
         <em>
          CHD7
         </em>
         ,
         <em>
          PROK2
         </em>
         ,
         <em>
          PROKR2
         </em>
         ), explaining one-third of cases [
         <a href="#rid60">
          60,61
         </a>
         ].
         <em>
          KAL1
         </em>
         gene is located on the X chromosome and encodes anosmin-1, an extracellular matrix protein which is involved in neuronal development, migration, and organogenesis. Anosmin-1 was detected in the basement membranes of mesonephric tubules and duct as well as branches of the ureteric bud [
         <a href="#rid62">
          62
         </a>
         ]. Forty percent of patients with
         <em>
          KAL1
         </em>
         gene mutations show renal anomalies, most often unilateral renal agenesis [
         <a href="#rid63">
          63
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7465.html" rel="external">
          "Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)", section on 'Genetics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Simpson-Golabi-Behmel syndrome
         </strong>
         – Simpson-Golabi-Behmel syndrome (SGBS;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F312870&amp;token=G%2BkOOgscg7PQzd0gXq5S90k4%2FM5uT2M6F436pjhGNhYLmU%2Fb1b4vWYcaCPBoYhXu&amp;TOPIC_ID=6083" target="_blank">
          OMIM #312870
         </a>
         ) is a rare X-linked congenital syndrome characterized by pre- and postnatal overgrowth, craniofacial anomalies, organomegaly, increased risk of tumors, moderate intellectual deficiency, and variable congenital malformations [
         <a href="#rid64">
          64
         </a>
         ]. Two types of the disorder have been described, a less severe form (SGBS type I) and a severe form (SGBS type II).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The glypican 3 (
         <em>
          GPC3
         </em>
         ) gene, located on Xq26, encodes a heparan sulfate proteoglycan, an extracellular matrix protein, which plays an important role in cell growth during development [
         <a href="#rid65">
          65
         </a>
         ].
         <em>
          GPC3
         </em>
         mutations have been identified mostly in patients with SGBS type I, the most frequent form of SGBS. Renal anomalies are observed in 50 percent of patients with
         <em>
          GPC3
         </em>
         mutations and consist of duplicated collecting, megaureter, VUR, and UPJO. Patients may have renal dysplasia and renal cysts, nephromegaly, and may develop Wilms tumor [
         <a href="#rid66">
          66
         </a>
         ]. A second locus on chromosome Xp22 is associated with SGBS type II.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fraser syndrome
         </strong>
         – Fraser syndrome (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F219000&amp;token=G%2BkOOgscg7PQzd0gXq5S92EhjsTXEjZMJ%2FhQoPvgjEIpne3UTAnSDxWh1AYPcV8K&amp;TOPIC_ID=6083" target="_blank">
          OMIM #219000
         </a>
         ) is an autosomal recessive disease characterized by cryptophthalmos, cutaneous syndactyly, genital malformations with ambiguous genitalia, craniofacial anomalies, and malformations of the larynx (stenosis or atresia) and the kidneys. Cryptophthalmos is bilateral, or less frequently, unilateral. Other ocular malformations include coloboma, microphthalmia, or anophthalmia. Bilateral renal agenesis was reported in 23 percent of 117 cases [
         <a href="#rid67">
          67
         </a>
         ]. Patients who survive may have unilateral renal agenesis and/or renal cystic dysplasia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Fraser syndrome occurs in 1 in 10,000 live births. Mutations in the
         <em>
          FRAS1
         </em>
         and
         <em>
          FREM2
         </em>
         genes have been described in patients with this syndrome [
         <a href="#rid68">
          68,69
         </a>
         ]. Both genes are involved in kidney development in the embryo.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pallister-Hall syndrome
         </strong>
         – Pallister-Hall syndrome (PHS;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F146510&amp;token=G%2BkOOgscg7PQzd0gXq5S90YPUd0IPLx1kRh31DvU%2FhmZ8l8MtyBnnmMJ2AbT%2BX79&amp;TOPIC_ID=6083" target="_blank">
          OMIM #146510
         </a>
         ) is a rare autosomal dominant disorder caused by mutations in
         <em>
          GLI3
         </em>
         , which encodes a transcriptional repressor (GLI3R). Clinical features include hypothalamic hamartoma, central and postaxial polydactyly, bifid epiglottis, imperforate anus, and renal abnormalities including renal dysplasia [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cenani-Lenz syndrome
         </strong>
         – Cenani-Lenz syndrome (CLS;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F212780&amp;token=G%2BkOOgscg7PQzd0gXq5S9%2FBhMqQrJP8sfQQ8RX7UVT5sqPVbznyw9UMO216WZV5F&amp;TOPIC_ID=6083" target="_blank">
          OMIM #212780
         </a>
         ) is an autosomal recessive congenital disorder affecting distal limb development. It is characterized mainly by syndactyly and/or oligodactyly and is associated with facial dysmorphism and kidney agenesis or hypodysplasia. CLS is caused by mutations in the
         <em>
          LRP4
         </em>
         gene, encoding the low-density lipoprotein receptor-related protein 4 [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          HDR syndrome
         </strong>
         – HDR syndrome (OMIM #146255) is an autosomal dominant genetic disease characterized by hypoparathyroidism, sensorineural deafness, and renal malformations including renal hypodysplasia, renal agenesis, and vesicoureteral reflux. Penetrance of these renal malformations is variable [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Haploinsufficiency for
         <em>
          GATA3
         </em>
         is the underlying mechanism of HDR syndrome. This gene belongs to a family of zinc finger transcription factors that are involved in vertebrate embryonic development [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          CHARGE syndrome
         </strong>
         – Infants with CHARGE syndrome (coloboma of the retina or the iris, heart anomalies, choanal atresia, intellectual disability, genital and ear anomalies;
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F214800&amp;token=G%2BkOOgscg7PQzd0gXq5S99J6YSvLZxYRGSEckxh36YRD1DWxRmyh10VmvsZq73kH&amp;TOPIC_ID=6083" target="_blank">
          OMIM #214800
         </a>
         ) [
         <a href="#rid74">
          74
         </a>
         ] often have renal or urological anomalies, such as unilateral renal agenesis, renal hypoplasia, duplex kidneys, UPJO, or VUR [
         <a href="#rid75">
          75
         </a>
         ]. Most cases of CHARGE syndrome are related to mutations of the gene coding for the chromodomain helicase DNA-binding protein-7 (
         <em>
          CHD7
         </em>
         ) on chromosome 8q12 [
         <a href="#rid76">
          76,77
         </a>
         ]. These are heterozygous mutations, suggesting that haploinsufficiency of the gene is responsible for CHARGE syndrome (autosomal dominant inheritance). Most cases are due to de novo mutations, although rare familial cases have been reported [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/83396.html" rel="external">
          "DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis", section on 'CHARGE syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2166514180">
         <span class="h2">
          Environmental causes of renal hypodysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following fetal and neonatal environmental factors have been suggested as contributing to reduced number of nephrons:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intrauterine growth restriction [
         <a href="#rid79">
          79
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal vitamin A deficiency [
         <a href="#rid80">
          80-82
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal low folate intake [
         <a href="#rid83">
          83
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal hyperglycemia and diabetes [
         <a href="#rid84">
          84-86
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal use of cocaine [
         <a href="#rid87">
          87
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal excessive alcohol consumption [
         <a href="#rid88">
          88
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal intake of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers [
         <a href="#rid89">
          89
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H849838667">
         <span class="h1">
          ANTENATAL PRESENTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal hypoplasia may be detected by antenatal ultrasound screening after the third month of gestation.
        </p>
        <p>
         The diagnosis of hypoplasia should be suspected when fetal renal measurements using reference charts demonstrate that the kidneys are less than fifth percentile  (
         <a class="graphic graphic_table graphicRef74636" href="/z/d/graphic/74636.html" rel="external">
          table 2
         </a>
         ). Ultrasound may demonstrate absence of corticomedullary differentiation, cysts, and dilatation of the urinary tract. In addition, oligohydramnios may also be a clue to bilateral renal malformation that results in decreased production of fetal urine (amniotic fluid). (See
         <a class="medical medical_review" href="/z/d/html/6106.html" rel="external">
          "Evaluation of congenital anomalies of the kidney and urinary tract (CAKUT)", section on 'Antenatal screening'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6777.html" rel="external">
          "Oligohydramnios: Etiology, diagnosis, and management in singleton gestations"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/462.html" rel="external">
          "Assessment of amniotic fluid volume"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4143440142">
         <span class="h1">
          POSTNATAL PRESENTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with a unilateral abnormality and normal contralateral kidney have normal renal function. In those with bilateral renal involvement, the clinical presentation is dependent on the degree of renal impairment. Patients with more severe involvement will present at a younger age. (See
         <a class="local">
          'Progression to end stage renal disease (ESRD)'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H998007311">
         <span class="h2">
          Neonate
         </span>
         <span class="headingEndMark">
          —
         </span>
         The birth weight (BW) of patients with renal hypodysplasia is often below the normal mean because of the association with intrauterine growth restriction (IUGR).
        </p>
        <p>
         In the neonatal period, patients may present with one or more of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pneumothorax
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Feeding difficulties
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic acidosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary sodium losses
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Impaired renal function based on elevated serum/plasma creatinine level
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H747242322">
         <span class="h2">
          First year of life
         </span>
         <span class="headingEndMark">
          —
         </span>
         During the first year of life, persistent anorexia with vomiting is the usual presentation of renal hypodysplasia. Failure to thrive is seen in more than 50 percent of cases. The degree of poor growth is greater than what would be expected based on the level of the infant's renal function impairment. (See
         <a class="medical medical_review" href="/z/d/html/14555.html" rel="external">
          "Growth failure in children with chronic kidney disease: Risk factors, evaluation, and diagnosis", section on 'Infancy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H662278919">
         <span class="h2">
          After one year of life
         </span>
         <span class="headingEndMark">
          —
         </span>
         After one year of age, patients will commonly present with proteinuria discovered incidentally on routine urine examination. In other patients, the disease may be discovered because of poor growth, or symptoms of polyuria and polydipsia. Renal failure can also present as anemia or osteodystrophy secondary to hyperparathyroidism. (See
         <a class="medical medical_review" href="/z/d/html/14555.html" rel="external">
          "Growth failure in children with chronic kidney disease: Risk factors, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6092.html" rel="external">
          "Pediatric chronic kidney disease-mineral and bone disorder (CKD-MBD)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3502291935">
         <span class="h2">
          Ultrasound findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Kidney hypoplasia is defined as reduced kidney size (less than two standard deviation scores for length [
         <a href="#rid90">
          90
         </a>
         ]) with normal corticomedullary differentiation, as detected on ultrasonography [
         <a href="#rid91">
          91
         </a>
         ]. Ultrasonography typically reveals reduced corticomedullary differentiation when there is renal dysplasia [
         <a href="#rid92">
          92,93
         </a>
         ]. Other findings may include reduced cortical thickness and cysts. Visualization of the urinary tract also may reveal urological malformations.
        </p>
        <p>
         Renal hypodysplasia may be either bilateral or unilateral. In cases of unilateral involvement, compensatory hypertrophy of the contralateral kidney is generally present [
         <a href="#rid94">
          94
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6746.html" rel="external">
          "Renal agenesis: Prenatal diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2066912363">
         <span class="h1">
          DIAGNOSIS AND EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H222574229">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal hypodysplasia is usually clinically diagnosed based on renal ultrasonography findings of a reduction of renal size by greater than two standard deviations for the mean size by age and loss of corticomedullary differentiation. The diagnosis can be confirmed by histologic examination; however, this is not usually performed since it would not impact management.
        </p>
        <p class="headingAnchor" id="H861479427">
         <span class="h2">
          Postdiagnosis evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         No further work-up is needed for patients with isolated renal hypodysplasia unless there is concern for an underlying genetic disorder because (see
         <a class="local">
          'Genetic disorders'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a strong family history suggestive of a specific underlying genetic disorder.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Or
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients have concomitant features suggestive of an underlying genetic disorder  (
         <a class="graphic graphic_table graphicRef108138" href="/z/d/graphic/108138.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         In these cases, work-up is warranted for those specific disorders if genetic testing is available.
        </p>
        <p class="headingAnchor" id="H2397227264">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of renal hypodysplasia in children who present beyond the neonatal period includes disorders that result in renal scarring, particularly recurrent episodes of pyelonephritis. 99mTc-dimercaptosuccinic acid (DMSA) radionuclide scan can be performed to distinguish hypoplastic kidneys from those with renal scarring. (See
         <a class="medical medical_review" href="/z/d/html/5991.html" rel="external">
          "Urinary tract infections in infants older than one month and children less than two years: Acute management, imaging, and prognosis", section on 'Kidney scintigraphy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6094.html" rel="external">
          "Clinical presentation, diagnosis, and course of primary vesicoureteral reflux", section on 'Kidney scarring'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2140539781">
         <span class="h1">
          PROGRESSION TO END STAGE RENAL DISEASE (ESRD)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Over time, many patients with renal hypodysplasia develop ESRD [
         <a href="#rid95">
          95
         </a>
         ]. Progressive renal failure is due, in part, to focal segmental glomerulosclerosis (FSGS), which develops in the reduced number of nephrons due to hyperfiltration, resulting in compensatory intraglomerular hypertension and hypertrophy. This process is similar to that seen with other renal conditions with nephron loss, and may be slowed by antihypertensive therapy, particularly with an angiotensin-converting enzyme (ACE) inhibitor. (See
         <a class="local">
          'Renal histopathology of ESRD'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/7169.html" rel="external">
          "Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117558.html" rel="external">
          "Focal segmental glomerulosclerosis: Pathogenesis", section on 'Pathogenesis of secondary FSGS'
         </a>
         .)
        </p>
        <p>
         Large case series have provided information on the natural course of renal function, based on estimated glomerular filtration rate (eGFR) of patients with renal hypodysplasia, which can be separated into three phases [
         <a href="#rid95">
          95-98
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During the first years of life, eGFR improves to a maximal level that is attained between one and six years of age. In general, maximal eGFR is achieved at a younger age in patients with the most severe degree of impairment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During the second phase, the maximal eGFR usually remains stable through early to middle childhood (&lt;10 years of age).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Near or at the onset of puberty, eGFR may deteriorate. Patients with proteinuria, recurrent urinary tract infections, hydronephrosis, and a solitary kidney are more likely to have a decline in eGFR and progress to ESRD. Proteinuria generally precedes the deterioration of renal function by several years.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2710913622">
         <span class="h2">
          Renal histopathology of ESRD
         </span>
         <span class="headingEndMark">
          —
         </span>
         Kidneys removed in patients with end-stage renal disease (ESRD) due to renal hypodysplasia at the time of transplantation are very small in size with a reduced number of papillae. In this setting, histological examination allows the clinician to confirm or to make the diagnosis of renal hypodysplasia:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The number of glomerular generations is extremely reduced, and varies from two to six depending in part upon the area of the kidney examined. By comparison, the normal number is at least 10.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a relatively high proportion of hypertrophic glomeruli. The diameter of these glomeruli is increased to more than 300 microns and often reaches 400 microns (in contrast, normal glomeruli have a diameter of 100 to 150 microns). Adjacent proximal tubules are also similarly hypertrophied.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other findings include segmental sclerosis, hyalinosis of glomeruli, and interstitial fibrosis [
         <a href="#rid96">
          96,99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3260777505">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management is based on the probability of progression to chronic kidney disease (CKD), which is more likely with bilateral involvement.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with
         <strong>
          unilateral
         </strong>
         hypodysplasia, follow-up ultrasounds are used to monitor the growth of the contralateral kidney, which typically exhibits compensatory hypertrophy [
         <a href="#rid94">
          94
         </a>
         ]. In addition, renal function studies are performed, particularly in patients who do not exhibit appropriate growth of the contralateral kidney.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with
         <strong>
          bilateral
         </strong>
         renal hypodysplasia, follow-up includes assessment of blood pressure and proteinuria twice a year and kidney function every six months for the first year, with subsequent assessments according to kidney function [
         <a href="#rid91">
          91
         </a>
         ]
         <strong>
          .
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Such patients need supportive management, which includes maintaining fluid and electrolyte balance, and growth promotion. The latter may entail the use of
         <a class="drug drug_pediatric" data-topicid="13354" href="/z/d/drug information/13354.html" rel="external">
          recombinant human growth hormone
         </a>
         (rHGH) therapy. (See
         <a class="medical medical_review" href="/z/d/html/6140.html" rel="external">
          "Growth failure in children with chronic kidney disease: Treatment with growth hormone"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As noted above, angiotensin-converting enzyme (ACE) inhibitors may be given in an attempt to slow the progression to end-stage renal failure, particularly in those patients who develop proteinuria. (See
         <a class="local">
          'Progression to end stage renal disease (ESRD)'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6085.html" rel="external">
          "Chronic kidney disease in children: Overview of management", section on 'Slow progression of chronic kidney disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7171.html" rel="external">
          "Antihypertensive therapy and progression of chronic kidney disease: Experimental studies"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other management issues are similar to those seen in children with CKD due to other disorders and are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6085.html" rel="external">
          "Chronic kidney disease in children: Overview of management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For patients who progress to end-stage renal disease (ESRD), renal transplantation is the preferred replacement therapy. (See
         <a class="medical medical_review" href="/z/d/html/6120.html" rel="external">
          "Kidney transplantation in children: General principles", section on 'Advantages of kidney transplantation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2433232145">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and pathogenesis
         </strong>
         – Renal hypodysplasia is characterized by small kidneys (hypoplasia) with malformed renal tissue elements (dysplasia) including primitive tubules, interstitial fibrosis, and/or the presence of cartilage. It is thought to be caused by disruption of normal renal development between the 14
         <sup>
          th
         </sup>
         and 20
         <sup>
          th
         </sup>
         weeks of fetal life. During this time period, ureteric bud branching defects due to either a vascular or genetic abnormality result in the developmental arrest of the metanephric renal blastema. (See
         <a class="local">
          'Renal malformations'
         </a>
         above and
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes
         </strong>
         – Renal hypodysplasia may occur as an isolated finding, in association with urinary tract malformations, or as a component of a genetic syndrome  (
         <a class="graphic graphic_table graphicRef108138" href="/z/d/graphic/108138.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antenatal detection
         </strong>
         – Renal hypoplasia may be detected by antenatal ultrasound screening after the third month of gestation. The diagnosis of hypoplasia should be suspected when fetal renal measurements using reference charts demonstrate that the kidneys are less than fifth percentile  (
         <a class="graphic graphic_table graphicRef74636" href="/z/d/graphic/74636.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Antenatal presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postnatal clinical features
         </strong>
         – Postnatal presentation for patients not detected by antenatal ultrasound screening is dependent on the degree of renal impairment. Patients with more severe involvement will present at a younger age, often during the neonatal period. (See
         <a class="local">
          'Postnatal presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neonates may present with pneumothorax, intrauterine growth restriction (IUGR), feeding difficulties, metabolic acidosis, and impaired renal function based on an elevated serum/plasma creatinine level.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Older infants typically present with failure to thrive, anorexia, and vomiting.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Children commonly present with proteinuria discovered incidentally on routine urine examination.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis by ultrasound –
         </strong>
         The clinical diagnosis of renal hypodysplasia is made by renal ultrasonography findings of a reduction of renal size by greater than two standard deviations for the mean size by age and loss of corticomedullary differentiation. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Over time, many patients with renal hypodysplasia progress to end-stage renal disease (ESRD). Progressive renal failure is due, in part, to focal segmental glomerulosclerosis (FSGS), which develops in the reduced number of nephrons, because of hyperfiltration resulting in compensatory intraglomerular hypertension and hypertrophy. (See
         <a class="local">
          'Progression to end stage renal disease (ESRD)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – There is no specific treatment for renal hypodysplasia. Supportive care includes maintaining fluid and electrolyte balance and promoting growth. Renal transplantation is the preferred therapy in patients who progress to ESRD. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Bertram JF, Douglas-Denton RN, Diouf B, et al. Human nephron number: implications for health and disease. Pediatr Nephrol 2011; 26:1529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murugapoopathy V, Gupta IR. A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT). Clin J Am Soc Nephrol 2020; 15:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitakado H, Horinouchi T, Masuda C, et al. Clinical and pathological investigation of oligomeganephronia. Pediatr Nephrol 2023; 38:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ROYER P, HABIB R, MATHIEU H, COURTECUISSE V. [Congenital bilateral renal hyperplasia with reduction of the number and hypertrophy of the nephrons in children]. Ann Pediatr (Paris) 1962; 9:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morita T, Wenzl J, McCoy J, et al. Bilateral renal hypoplasia with oligomeganephronia: quantitative and electron microsopic study. Am J Clin Pathol 1973; 59:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet 2007; 8:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foster SV, Hawkins EP. Deficient metanephric blastema--a cause of oligomeganephronia? Pediatr Pathol 1994; 14:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansour A, Reye RD, Roy LP. Oligomeganephronia with covered anus in twins. Aust Paediatr J 1977; 13:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng WL, Cheung MF, Chan CW, Yu CL. Oligomeganephronic renal hypoplasia. Pathology 1980; 12:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weir MR, Salinas JA, Rawlings PC. Intrauterine twin demise and oligomeganephronia. Nephron 1985; 40:482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerecuk L, Schreuder MF, Woolf AS. Renal tract malformations: perspectives for nephrologists. Nat Clin Pract Nephrol 2008; 4:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber S, Moriniere V, Knüppel T, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol 2006; 17:2864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woolf AS. Renal hypoplasia and dysplasia: starting to put the puzzle together. J Am Soc Nephrol 2006; 17:2647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang DY, Dworschak GC, Kohl S, et al. Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int 2014; 85:1429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber S, Taylor JC, Winyard P, et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol 2008; 19:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schönfelder EM, Knüppel T, Tasic V, et al. Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans. Am J Kidney Dis 2006; 47:1004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanna-Cherchi S, Sampogna RV, Papeta N, et al. Mutations in DSTYK and dominant urinary tract malformations. N Engl J Med 2013; 369:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanna-Cherchi S, Khan K, Westland R, et al. Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations. Am J Hum Genet 2017; 101:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verbitsky M, Westland R, Perez A, et al. The copy number variation landscape of congenital anomalies of the kidney and urinary tract. Nat Genet 2019; 51:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gubler MC. Renal tubular dysgenesis. Pediatr Nephrol 2014; 29:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allanson JE, Hunter AG, Mettler GS, Jimenez C. Renal tubular dysgenesis: a not uncommon autosomal recessive syndrome: a review. Am J Med Genet 1992; 43:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gubler MC, Antignac C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int 2010; 77:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schreiber R, Gubler MC, Gribouval O, et al. Inherited renal tubular dysgenesis may not be universally fatal. Pediatr Nephrol 2010; 25:2531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gribouval O, Gonzales M, Neuhaus T, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005; 37:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gribouval O, Morinière V, Pawtowski A, et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat 2012; 33:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraser FC, Ling D, Clogg D, Nogrady B. Genetic aspects of the BOR syndrome--branchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978; 2:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez Soriano J. Branchio-oto-renal syndrome. J Nephrol 2003; 16:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melnick M, Bixler D, Silk K, et al. Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 1975; 11:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen A, Francis M, Ni L, et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995; 58:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdelhak S, Kalatzis V, Heilig R, et al. Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet 1997; 6:2247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orten DJ, Fischer SM, Sorensen JL, et al. Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum Mutat 2008; 29:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu PX, Adams J, Peters H, et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999; 23:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoskins BE, Cramer CH, Silvius D, et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80:800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruf RG, Xu PX, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101:8090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kochhar A, Orten DJ, Sorensen JL, et al. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum Mutat 2008; 29:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weaver RG, Cashwell LF, Lorentz W, et al. Optic nerve coloboma associated with renal disease. Am J Med Genet 1988; 29:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dureau P, Attie-Bitach T, Salomon R, et al. Renal coloboma syndrome. Ophthalmology 2001; 108:1912.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eccles MR, Schimmenti LA. Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations. Clin Genet 1999; 56:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schimmenti LA, Cunliffe HE, McNoe LA, et al. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 1997; 60:869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bower M, Salomon R, Allanson J, et al. Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat 2012; 33:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salomon R, Tellier AL, Attie-Bitach T, et al. PAX2 mutations in oligomeganephronia. Kidney Int 2001; 59:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimoto K, Iijima K, Shirakawa T, et al. PAX2 gene mutation in a family with isolated renal hypoplasia. J Am Soc Nephrol 2001; 12:1769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Decramer S, Parant O, Beaufils S, et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 2007; 18:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ulinski T, Lescure S, Beaufils S, et al. Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. J Am Soc Nephrol 2006; 17:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lebrun G, Vasiliu V, Bellanné-Chantelot C, et al. Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations. Nat Clin Pract Nephrol 2005; 1:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes. J Am Soc Nephrol 2016; 27:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellanné-Chantelot C, Chauveau D, Gautier JF, et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004; 140:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yorifuji T, Kurokawa K, Mamada M, et al. Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism. J Clin Endocrinol Metab 2004; 89:2905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moreno-De-Luca D, SGENE Consortium, Mulle JG, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet 2010; 87:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loirat C, Bellanné-Chantelot C, Husson I, et al. Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion. Nephrol Dial Transplant 2010; 25:3430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heidet L, Decramer S, Pawtowski A, et al. Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol 2010; 5:1079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopez-Rivera E, Liu YP, Verbitsky M, et al. Genetic Drivers of Kidney Defects in the DiGeorge Syndrome. N Engl J Med 2017; 376:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell CM, Michaelis RC. Townes-Brocks syndrome. J Med Genet 1999; 36:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kohlhase J, Wischermann A, Reichenbach H, et al. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat Genet 1998; 18:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller EM, Hopkin R, Bao L, Ware SM. Implications for genotype-phenotype predictions in Townes-Brocks syndrome: case report of a novel SALL1 deletion and review of the literature. Am J Med Genet A 2012; 158A:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishinakamura R, Takasato M. Essential roles of Sall1 in kidney development. Kidney Int 2005; 68:1948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borozdin W, Steinmann K, Albrecht B, et al. Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome. Hum Mutat 2006; 27:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karstensen HG, Tommerup N. Isolated and syndromic forms of congenital anosmia. Clin Genet 2012; 81:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardelin JP, Dodé C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2008; 2:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodé C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006; 2:e175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardelin JP, Julliard AK, Moniot B, et al. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 1999; 215:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirk JM, Grant DB, Besser GM, et al. Unilateral renal aplasia in X-linked Kallmann's syndrome. Clin Genet 1994; 46:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neri G, Gurrieri F, Zanni G, Lin A. Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet 1998; 79:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grisaru S, Rosenblum ND. Glypicans and the biology of renal malformations. Pediatr Nephrol 2001; 16:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cottereau E, Mortemousque I, Moizard MP, et al. Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. Am J Med Genet C Semin Med Genet 2013; 163C:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slavotinek AM, Tifft CJ. Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes. J Med Genet 2002; 39:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jadeja S, Smyth I, Pitera JE, et al. Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet 2005; 37:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGregor L, Makela V, Darling SM, et al. Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 2003; 34:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Démurger F, Ichkou A, Mougou-Zerelli S, et al. New insights into genotype-phenotype correlation for GLI3 mutations. Eur J Hum Genet 2015; 23:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Pawlik B, Elcioglu N, et al. LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome. Am J Hum Genet 2010; 86:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemos MC, Thakker RV. Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 Years after the identification of the first GATA3 mutations. Hum Mutat 2020; 41:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Esch H, Groenen P, Nesbit MA, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000; 406:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A 2005; 133A:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ragan DC, Casale AJ, Rink RC, et al. Genitourinary anomalies in the CHARGE association. J Urol 1999; 161:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jongmans MC, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet 2006; 43:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vissers LE, van Ravenswaaij CM, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004; 36:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lalani SR, Safiullah AM, Fernbach SD, et al. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet 2006; 78:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hinchliffe SA, Lynch MR, Sargent PH, et al. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodyer P, Kurpad A, Rekha S, et al. Effects of maternal vitamin A status on kidney development: a pilot study. Pediatr Nephrol 2007; 22:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           WILSON JG, ROTH CB, WARKANY J. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 1953; 92:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lelièvre-Pégorier M, Vilar J, Ferrier ML, et al. Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 1998; 54:1455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amri K, Freund N, Vilar J, et al. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes 1999; 48:2240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abi Khalil C, Travert F, Fetita S, et al. Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age. Diabetes 2010; 59:2631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cappuccini B, Torlone E, Ferri C, et al. Renal echo-3D and microalbuminuria in children of diabetic mothers: a preliminary study. J Dev Orig Health Dis 2013; 4:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Battin M, Albersheim S, Newman D. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol 1995; 12:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qazi Q, Masakawa A, Milman D, et al. Renal anomalies in fetal alcohol syndrome. Pediatrics 1979; 63:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinovic J, Benachi A, Laurent N, et al. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 2001; 358:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Obrycki Ł, Sarnecki J, Lichosik M, et al. Kidney length normative values in children aged 0-19 years - a multicenter study. Pediatr Nephrol 2022; 37:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kohl S, Avni FE, Boor P, et al. Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations. Nephrol Dial Transplant 2022; 37:2351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han BK, Babcock DS. Sonographic measurements and appearance of normal kidneys in children. AJR Am J Roentgenol 1985; 145:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klare B, Geiselhardt B, Wesch H, et al. Radiological kidney size in childhood. Pediatr Radiol 1980; 9:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidovits M, Cleper R, Eizenberg N, et al. Outcomes of prenatally diagnosed solitary functioning kidney during early life. J Perinatol 2017; 37:1325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanna-Cherchi S, Ravani P, Corbani V, et al. Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 2009; 76:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broyer M, Soto B, Gagnadoux MF, et al. Oligomeganephronic renal hypoplasia. Adv Nephrol Necker Hosp 1997; 26:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quirino IG, Diniz JS, Bouzada MC, et al. Clinical course of 822 children with prenatally detected nephrouropathies. Clin J Am Soc Nephrol 2012; 7:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           González Celedón C, Bitsori M, Tullus K. Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 2007; 22:1014.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989; 13:443.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6083 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21604189" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Human nephron number: implications for health and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32188635" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35861872" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical and pathological investigation of oligomeganephronia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14494740" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : [Congenital bilateral renal hyperplasia with reduction of the number and hypertrophy of the nephrons in children].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4688553" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Bilateral renal hypoplasia with oligomeganephronia: quantitative and electron microsopic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17878895" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Renal abnormalities and their developmental origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7855013" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Deficient metanephric blastema--a cause of oligomeganephronia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/565200" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Oligomeganephronia with covered anus in twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7465259" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Oligomeganephronic renal hypoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4040612" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Intrauterine twin demise and oligomeganephronia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18446149" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Renal tract malformations: perspectives for nephrologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16971658" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16959822" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Renal hypoplasia and dysplasia: starting to put the puzzle together.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24429398" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18305125" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : SIX2 and BMP4 mutations associate with anomalous kidney development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16731295" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23862974" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Mutations in DSTYK and dominant urinary tract malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29100090" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30578417" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The copy number variation landscape of congenital anomalies of the kidney and urinary tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23636579" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Renal tubular dysgenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1642268" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Renal tubular dysgenesis: a not uncommon autosomal recessive syndrome: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19924102" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Renin-angiotensin system in kidney development: renal tubular dysgenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20607303" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Inherited renal tubular dysgenesis may not be universally fatal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16116425" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22095942" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/263442" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Genetic aspects of the BOR syndrome--branchial fistulas, ear pits, hearing loss, and renal anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14696767" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Branchio-oto-renal syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1218203" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Autosomal dominant branchiootorenal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8533848" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Phenotypic manifestations of branchio-oto-renal syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9361030" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18220287" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10471511" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17357085" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15141091" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18330911" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7795640" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3377002" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Optic nerve coloboma associated with renal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11581073" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Renal coloboma syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10466411" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9106533" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22213154" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11168927" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : PAX2 mutations in oligomeganephronia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11461952" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : PAX2 gene mutation in a family with isolated renal hypoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17267738" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16371430" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16932376" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26319241" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15068978" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15181075" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21055719" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20587423" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20378641" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28121514" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Genetic Drivers of Kidney Defects in the DiGeorge Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10051003" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Townes-Brocks syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9425907" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22308078" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Implications for genotype-phenotype predictions in Townes-Brocks syndrome: case report of a novel SALL1 deletion and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16221172" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Essential roles of Sall1 in kidney development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16429401" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21895637" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Isolated and syndromic forms of congenital anosmia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18987492" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17054399" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10340754" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7820942" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Unilateral renal aplasia in X-linked Kallmann's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9781908" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11322381" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Glypicans and the biology of renal malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23606591" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12205104" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15838507" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12766769" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24736735" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : New insights into genotype-phenotype correlation for GLI3 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20381006" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32442337" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 Years after the identification of the first GATA3 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10935639" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : GATA3 haplo-insufficiency causes human HDR syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15666308" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Updated diagnostic criteria for CHARGE syndrome: a proposal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9915472" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Genitourinary anomalies in the CHARGE association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16155193" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15300250" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16400610" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1581274" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : The effect of intrauterine growth retardation on the development of renal nephrons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17093988" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Effects of maternal vitamin A status on kidney development: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13030424" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9844121" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Mild vitamin A deficiency leads to inborn nephron deficit in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11096168" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Folic acid antagonists during pregnancy and the risk of birth defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10535460" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20622173" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24993001" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Renal echo-3D and microalbuminuria in children of diabetic mothers: a preliminary study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8579655" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Congenital genitourinary tract abnormalities following cocaine exposure in utero.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/450525" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Renal anomalies in fetal alcohol syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11480433" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Fetal toxic effects and angiotensin-II-receptor antagonists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34657197" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Kidney length normative values in children aged 0-19 years - a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35772019" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3895872" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Sonographic measurements and appearance of normal kidneys in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7393670" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Radiological kidney size in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29072675" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Outcomes of prenatally diagnosed solitary functioning kidney during early life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19536081" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Renal outcome in patients with congenital anomalies of the kidney and urinary tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8922124" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Oligomeganephronic renal hypoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22266574" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Clinical course of 822 children with prenatally detected nephrouropathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17380351" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Progression of chronic renal failure in children with dysplastic kidneys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2658558" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
